Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'07
No of Months
12
12
12
Operating Income
707.00
653.00
130.00
Less :Inter divisional transfers
0.00
0.00
0.00
Less: Excise
0.00
0.00
9.00
Net Sales
707.00
653.00
120.00
Expenditure (Ex Depriciation)
Stock Adjustments
-21.00
8.00
3.00
Raw Materials Consumed
274.00
205.00
38.00
Power & Fuel Cost
18.00
17.00
3.00
Employee Cost
141.00
126.00
20.00
Operating Expenses
30.00
29.00
7.00
General and Administration Expenses
-1.00
-1.00
13.00
Selling and Distribution Expenses
31.00
35.00
5.00
Cost of Software developments
0.00
0.00
0.00
Miscellaneous Expenses
18.00
11.00
7.00
Expenses Capitalised
0.00
0.00
0.00
Total Expenditure
559.00
492.00
98.00
Operating Profit (PBDIT) excl Other Income
147.00
160.00
22.00
Other Income
25.00
12.00
3.00
Operating Profit (PBDIT)
173.00
173.00
26.00
Interest
1.00
1.00
11.00
Profit before Depriciation and Tax
171.00
171.00
14.00
Depreciation
21.00
21.00
4.00
Profit Before Taxation & Exceptional Items
150.00
150.00
9.00
Exceptional Income / Expenses
0.00
0.00
0.00
Profit Before Tax
154.00
232.00
9.00
Provision for Tax
39.00
49.00
1.00
Profit After Tax
115.00
183.00
8.00
Extraordinary Items
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
1.00
Profit Balance B/F
474.00
318.00
-10.00
Profit Available for appropriations
589.00
501.00
-1.00
Appropriations
589.00
501.00
-1.00
Equity Dividend (%)
300.00%
300.00%
15.00%
Earnings Per Share
69.64
110.80
5.75
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 8.28% vs NA in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is -7.88% vs NA in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 11.32% vs NA in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is -37.15% vs NA in Mar 2025
Compare Profit and Loss Results of RPG LifeScience.
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
707.00
927.00
-220.00
-23.73%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
707.00
927.00
-220.00
-23.73%
Expenditure (Ex Depriciation)
Stock Adjustments
-21.00
-22.00
1.00
4.55%
Raw Materials Consumed
274.00
447.00
-173.00
-38.70%
Power & Fuel Cost
18.00
14.00
4.00
28.57%
Employee Cost
141.00
136.00
5.00
3.68%
Operating Expenses
30.00
22.00
8.00
36.36%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
31.00
93.00
-62.00
-66.67%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
18.00
43.00
-25.00
-58.14%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
559.00
763.00
-204.00
-26.74%
Operating Profit (PBDIT) excl Other Income
147.00
164.00
-17.00
-10.37%
Other Income
25.00
73.00
-48.00
-65.75%
Operating Profit (PBDIT)
173.00
237.00
-64.00
-27.00%
Interest
1.00
12.00
-11.00
-91.67%
Profit before Depriciation and Tax
171.00
225.00
-54.00
-24.00%
Depreciation
21.00
33.00
-12.00
-36.36%
Profit Before Taxation & Exceptional Items
150.00
192.00
-42.00
-21.88%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
154.00
189.00
-35.00
-18.52%
Provision for Tax
39.00
54.00
-15.00
-27.78%
Profit After Tax
115.00
134.00
-19.00
-14.18%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
474.00
966.00
-492.00
-50.93%
Profit Available for appropriations
589.00
1,095.00
-506.00
-46.21%
Appropriations
589.00
1,095.00
-506.00
-46.21%
Equity Dividend (%)
300%
50%
250.00
Earnings Per Share
69.64
12.23
57.41
469.42%
Profit And Loss - Net Sales
Net Sales 707.52 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 8.28% vs NA in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 147.97 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -7.88% vs NA in Mar 2025
Profit And Loss - Interest
Interest 1.77 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 11.32% vs NA in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 115.17 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -37.15% vs NA in Mar 2025






